Association between serum ceruloplasmin levels and arterial stiffness in korean men with type 2 diabetes mellitus

Min Jung Lee, Chang Hee Jung, Jenie Yoonoo Hwang, Mi Seon Shin, Ji Hee Yu, Woo Je Lee, Joong Yeol Park

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Increased oxidative stress contributes to the development of arterial stiffness. Arterial stiffness, as measured by brachial-ankle pulse wave velocity (baPWV), has been known to be correlated with oxidative stress. Serum ceruloplasmin (CP), a copper-carrying protein, may indicate the overall level of oxidative stress in the body. The present study investigated whether serum CP levels are associated with baPWV in Korean men with type 2 diabetes mellitus (DM). Subjects and Methods: Serum CP levels and conventional risk factors were measured in 760 Korean men with type 2 DM. Arterial stiffness was assessed by baPWV obtained with an automatic device (model VP-1000; Colin, Komaki, Japan). Results: Correlation analysis indicated a significant positive association between serum CP and baPWV (r=0.109, P=0.003). Age-adjusted baPWV increased gradually according to serum CP quartiles (Q1, 1,500.3±18.4 cm/s; Q2, 1,511.6±17.8 cm/s; Q3, 1,551.8±17.9 cm/s; Q4, 1,622.1±17.8 cm/s; P for trend<0.001). Multivariate linear regression analysis showed that serum CP was independently associated with baPWV in various models. Conclusions: A positive relationship was identified between CP and baPWV in adult male subjects with type 2 DM, which was independent of conventional cardiovascular risk factors. Further studies are needed to confirm whether CP contributes to the pathogenesis of increased arterial stiffness in subjects with type 2 DM.

Original languageEnglish
Pages (from-to)1091-1097
Number of pages7
JournalDiabetes Technology and Therapeutics
Volume14
Issue number12
DOIs
Publication statusPublished - 2012 Dec 1
Externally publishedYes

Fingerprint

Vascular Stiffness
Ceruloplasmin
Pulse Wave Analysis
Type 2 Diabetes Mellitus
Ankle
Arm
Serum
Oxidative Stress
Copper
Linear Models
Japan
Regression Analysis
Equipment and Supplies

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Association between serum ceruloplasmin levels and arterial stiffness in korean men with type 2 diabetes mellitus. / Lee, Min Jung; Jung, Chang Hee; Hwang, Jenie Yoonoo; Shin, Mi Seon; Yu, Ji Hee; Lee, Woo Je; Park, Joong Yeol.

In: Diabetes Technology and Therapeutics, Vol. 14, No. 12, 01.12.2012, p. 1091-1097.

Research output: Contribution to journalArticle

Lee, Min Jung ; Jung, Chang Hee ; Hwang, Jenie Yoonoo ; Shin, Mi Seon ; Yu, Ji Hee ; Lee, Woo Je ; Park, Joong Yeol. / Association between serum ceruloplasmin levels and arterial stiffness in korean men with type 2 diabetes mellitus. In: Diabetes Technology and Therapeutics. 2012 ; Vol. 14, No. 12. pp. 1091-1097.
@article{cd48003f1ec041e5803e603475773567,
title = "Association between serum ceruloplasmin levels and arterial stiffness in korean men with type 2 diabetes mellitus",
abstract = "Background: Increased oxidative stress contributes to the development of arterial stiffness. Arterial stiffness, as measured by brachial-ankle pulse wave velocity (baPWV), has been known to be correlated with oxidative stress. Serum ceruloplasmin (CP), a copper-carrying protein, may indicate the overall level of oxidative stress in the body. The present study investigated whether serum CP levels are associated with baPWV in Korean men with type 2 diabetes mellitus (DM). Subjects and Methods: Serum CP levels and conventional risk factors were measured in 760 Korean men with type 2 DM. Arterial stiffness was assessed by baPWV obtained with an automatic device (model VP-1000; Colin, Komaki, Japan). Results: Correlation analysis indicated a significant positive association between serum CP and baPWV (r=0.109, P=0.003). Age-adjusted baPWV increased gradually according to serum CP quartiles (Q1, 1,500.3±18.4 cm/s; Q2, 1,511.6±17.8 cm/s; Q3, 1,551.8±17.9 cm/s; Q4, 1,622.1±17.8 cm/s; P for trend<0.001). Multivariate linear regression analysis showed that serum CP was independently associated with baPWV in various models. Conclusions: A positive relationship was identified between CP and baPWV in adult male subjects with type 2 DM, which was independent of conventional cardiovascular risk factors. Further studies are needed to confirm whether CP contributes to the pathogenesis of increased arterial stiffness in subjects with type 2 DM.",
author = "Lee, {Min Jung} and Jung, {Chang Hee} and Hwang, {Jenie Yoonoo} and Shin, {Mi Seon} and Yu, {Ji Hee} and Lee, {Woo Je} and Park, {Joong Yeol}",
year = "2012",
month = "12",
day = "1",
doi = "10.1089/dia.2012.0177",
language = "English",
volume = "14",
pages = "1091--1097",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Association between serum ceruloplasmin levels and arterial stiffness in korean men with type 2 diabetes mellitus

AU - Lee, Min Jung

AU - Jung, Chang Hee

AU - Hwang, Jenie Yoonoo

AU - Shin, Mi Seon

AU - Yu, Ji Hee

AU - Lee, Woo Je

AU - Park, Joong Yeol

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Background: Increased oxidative stress contributes to the development of arterial stiffness. Arterial stiffness, as measured by brachial-ankle pulse wave velocity (baPWV), has been known to be correlated with oxidative stress. Serum ceruloplasmin (CP), a copper-carrying protein, may indicate the overall level of oxidative stress in the body. The present study investigated whether serum CP levels are associated with baPWV in Korean men with type 2 diabetes mellitus (DM). Subjects and Methods: Serum CP levels and conventional risk factors were measured in 760 Korean men with type 2 DM. Arterial stiffness was assessed by baPWV obtained with an automatic device (model VP-1000; Colin, Komaki, Japan). Results: Correlation analysis indicated a significant positive association between serum CP and baPWV (r=0.109, P=0.003). Age-adjusted baPWV increased gradually according to serum CP quartiles (Q1, 1,500.3±18.4 cm/s; Q2, 1,511.6±17.8 cm/s; Q3, 1,551.8±17.9 cm/s; Q4, 1,622.1±17.8 cm/s; P for trend<0.001). Multivariate linear regression analysis showed that serum CP was independently associated with baPWV in various models. Conclusions: A positive relationship was identified between CP and baPWV in adult male subjects with type 2 DM, which was independent of conventional cardiovascular risk factors. Further studies are needed to confirm whether CP contributes to the pathogenesis of increased arterial stiffness in subjects with type 2 DM.

AB - Background: Increased oxidative stress contributes to the development of arterial stiffness. Arterial stiffness, as measured by brachial-ankle pulse wave velocity (baPWV), has been known to be correlated with oxidative stress. Serum ceruloplasmin (CP), a copper-carrying protein, may indicate the overall level of oxidative stress in the body. The present study investigated whether serum CP levels are associated with baPWV in Korean men with type 2 diabetes mellitus (DM). Subjects and Methods: Serum CP levels and conventional risk factors were measured in 760 Korean men with type 2 DM. Arterial stiffness was assessed by baPWV obtained with an automatic device (model VP-1000; Colin, Komaki, Japan). Results: Correlation analysis indicated a significant positive association between serum CP and baPWV (r=0.109, P=0.003). Age-adjusted baPWV increased gradually according to serum CP quartiles (Q1, 1,500.3±18.4 cm/s; Q2, 1,511.6±17.8 cm/s; Q3, 1,551.8±17.9 cm/s; Q4, 1,622.1±17.8 cm/s; P for trend<0.001). Multivariate linear regression analysis showed that serum CP was independently associated with baPWV in various models. Conclusions: A positive relationship was identified between CP and baPWV in adult male subjects with type 2 DM, which was independent of conventional cardiovascular risk factors. Further studies are needed to confirm whether CP contributes to the pathogenesis of increased arterial stiffness in subjects with type 2 DM.

UR - http://www.scopus.com/inward/record.url?scp=84871016898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871016898&partnerID=8YFLogxK

U2 - 10.1089/dia.2012.0177

DO - 10.1089/dia.2012.0177

M3 - Article

VL - 14

SP - 1091

EP - 1097

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 12

ER -